PS-DIAN (Methandienone Tablets 10 mg)
December 12, 2023PS-TURIN (Turinabol Tablets USP 10 mg)
December 12, 2023PS-STAN (Stanozolol Tablets USP 10 mg)
Number:
10 vials 1 ml
COMPOSITION:
Each ml contains: Trenbolone Enanthate USP 200 mg
PS-STAN
(Stanozolol Tablets USP 10 mg)
COMPOSITION:
Each tablet contains: Stanozolol USP 10 mg
Read this entire leaflet carefully before you use this medicine
INDICATIONS AND USAGE:
Hereditary Angioedema: for prophylactic use to decrease frequency and severity of attacks of angioedema. Muscle Anabolism: for adjunctive therapy in patients for weight gain following severe muscular atrophy associated with extensive surgery, chronic infections, long term hospitalization, or sever trauma. Corticosteroid atrophy: to reduce muscle wasting during prolonged corticosteroid use.
CONTRA-INDICATIONS:
- Female patients due to risk of virilization and fatal harm, 2. Male patients with known or suspected carcinoma of the breast, prostate, ontestis,
- Patients with hypercalcaemia as anabolic steroids may stimulate osteolytic bone resorption.
- Patients with cardiovascular disorders, renal or hepatic impairment, epilepsy, migraines, or diabetes mellitus. 5. Nephrosis or the nephrotic phase of nephritis.
- Hypersensitivity to stanozolol.
Drug interactions:
PS STAN may increase sensitivity to anticoagulants; therefore, dosage of an anticoagulant may have to be decreased in order to maintain the prothrombin time at the desired therapeutic level.
Over dosage:
Cholestatic hepatitis and jaundice occur with 17 alpha alkylated androgens at relatively low doses. If cholestic hepatitis with jaundice appears the stanozolol dose should be discontinued. If liver function tests become abnormal, the patient should be monitored closely and the aetiology determined. In patient with breast cancer anabolic steroid may cause hypercalcemia by stimulating osteolysis in this case the drug should be discontinued. Edema with or without congestive heart failure may be a serious” complication in patients with pre-existing cardiac, renal, or hepatic disease.
Precautions:
General: Women should be observed for signs of virilization (deepening of the voice, hirsutism, acne, and clitoromegaly). To prevent irreversible change, drug therapy must be
discontinued, or the dosage significantly reduced. Such virilization is usual following androgenic anabolic steroid use at high doses.
Some virilizing changes in women are irreversible even after prompt discontinuance of therapy and are not prevented by concomitant use of estrogens. Menstrual irregularities may also occur. The insulin or oral hypoglycemic dosage may need adjustment in diabetic patients who receive anabolic steroids.
Information for the Patient:
The physician should instruct patients to report any of the following side effects of androgens:
Adult or Adolescent
Males: Too frequent or persistent erections of the penis, appearance or aggravation of acne.
Women: Hoarseness, acne, changes in menstrual periods, or more hair on the face.
All Patients: Any nausea, vomiting. Change in skin color, or ankle swelling.
Laboratory Test: Women with disseminated breast carcinoma should have frequent determination of urine and serum calcium levels. Because of the hepatotoxicity associated with the use of 17-alphaalkylated androgens, liver function tests should be obtained periodically. Periodic (every 6 months) x-ray examinations of bone age should be made during treatment of prepubertal patients to determine the rate of bone maturation and the effects of androgenic anabolic steroid therapy on the epiphyseal centres. In common with other anabolic steroids..” STANAGE has been reported to lower the level of high-density.” “lipoproteins and raise the level of low-density lipoproteins. These changes usually revert to normal on discontinuation of treatment. Increased low-density lipoproteins and decreased high-density lipoproteins are considered cardiovascular risk factors.
DOSAGE AND ADMINISTRATION:
Muscle anabolism: 10-30 mg taken orally each day in divided. doses for duration of 4-6 weeks.
Hereditary angioedema: The dosage requirement for continuous treatment of hereditary angioedema with stanozolol should be individualized on the basis of the clinical response of the patient. Commonly 2-6 mg taken orally each day in divided doses initially and reduced by physician thereafter.
Effective dose for male: 50-100 mg per day Effective dose for female: 2.5-10 mg per day
ABUSE IN SPORTS.
Abuse of this product in sports is highly discouraged.PS LABS does not take any responsibility for use of this product for any other purpose. This product should be used under proper medical supervision,
Keep out of the reach and sight of children.
Related products
-
Sustanone
Number:
10 vials 1 ml
COMPOSITION:
Each ml contains: Sustanone Testosterone Mix 250 mg
-
Trenbolone Acetate
Number:
10 vials 1 ml
COMPOSITION:
Each ml contains: Trenbolone Acetate USP 100 mg
-
Testosterone Cypionate
Number:
10 vials 1 ml
COMPOSITION:
Each ml contains: Testosterone Cypionate USP 250 mg
Reviews
There are no reviews yet.